Atrial Fibrillation Trial Launched for Valve Patients
Researchers have started a study comparing catheter ablation to drug treatment for people recovering from mitral valve repair.
Updated on Sept. 22, 2026 in Heart Disease
Live Poll
Do you believe clinical research on heart treatments for older adults improves long-term health outcomes?
The Atrial Fibrillation Network has launched the CABA-MiTRA-AFNET12-DZHK34 clinical study to assess heart rhythm treatments in those who recently underwent mitral valve repair. This randomized trial aims to include 956 patients across 50 hospitals in Germany and Europe.
Why it matters
Atrial fibrillation is the most common cardiac arrhythmia, and mitral valve regurgitation is a frequent valve disease in older adults. This research aims to determine if catheter ablation offers superior protection against strokes and other complications compared to standard medication.
The CABA-MiTRA-AFNET12-DZHK34 study is a randomized clinical trial designed to enroll 956 patients who underwent mitral valve repair within the previous six months. Researchers are comparing catheter ablation outcomes against standard drug-based treatment protocols.
The players
Atrial Fibrillation Network
A research organization dedicated to investigating cardiac arrhythmias and improving patient treatment standards.
University Hospital Cologne
A major academic medical center in Germany that serves as a primary site for clinical research and patient care.
The details
Participants in the study are randomized to either receive catheter ablation or standard medical care. To track the effectiveness of these interventions, researchers may implant an event recorder in some patients to monitor atrial fibrillation burden over time. This approach allows clinicians to objectively measure how each treatment manages the arrhythmia in the wake of cardiac valve surgery.
Timeline
September 21, 2026: The first study participant was enrolled at University Hospital Cologne.
Health Landscape
This study sits within the broader research efforts supported by the German Center for Cardiovascular Research to optimize heart health outcomes. It addresses a critical gap in treating arrhythmia in patients already managing the complexities of mitral valve disease.
If you have recently undergone mitral valve repair and are experiencing an irregular heartbeat, it is worth discussing the evolving treatment landscape with your cardiologist. Understanding the pros and cons of catheter ablation versus medication is a conversation to have with your care team.
The takeaway
This trial highlights the ongoing effort to define the best rhythm management strategies for patients recovering from heart valve procedures. Patients should track their symptoms and consult their physician about current clinical research regarding arrhythmia management options.
Further reading
Learn more about the latest innovations in cardiac care by visiting our Heart Disease section.
More information
Review the clinical study details through the Atrial Fibrillation Network research portal.
Source note: This article includes information reported by Informationdienst Wissenschaft e.V. - idw.
Live Poll
Do you believe clinical research on heart treatments for older adults improves long-term health outcomes?
